85 related articles for article (PubMed ID: 8847049)
1. Expression of sialyl Lewis(x) in hepatocellular carcinoma.
Tori A; Harada A; Nakao A; Nonami T; Ito M; Takagi H
Hepatogastroenterology; 1995; 42(6):939-43. PubMed ID: 8847049
[TBL] [Abstract][Full Text] [Related]
2. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
[TBL] [Abstract][Full Text] [Related]
3. Expressions of Lewis antigens in human non-small cell pulmonary cancer and primary liver cancer with different pathological conditions.
Wang QY; Wu SL; Chen JH; Liu F; Chen HL
J Exp Clin Cancer Res; 2003 Sep; 22(3):431-40. PubMed ID: 14582703
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of sialyl Lewis(x) antigen in penetrating growth type A early gastric cancer.
Nakagoe T; Fukushima K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Tanaka K; Yamaguchi H; Yasutake T; Ayabe H; Ishikawa H
J Exp Clin Cancer Res; 2002 Sep; 21(3):363-9. PubMed ID: 12385579
[TBL] [Abstract][Full Text] [Related]
6. Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma.
Uenishi T; Kubo S; Hirohashi K; Yamamoto T; Ogawa M; Tanaka H; Shuto T; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1101-4. PubMed ID: 12845990
[TBL] [Abstract][Full Text] [Related]
7. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
8. Expression of Lewis blood group antigens in cancerous and non-cancerous liver.
Kanai T; Hirohashi S; Upton MP; Ino Y; Shimosato Y
Jpn J Cancer Res; 1987 Sep; 78(9):968-76. PubMed ID: 2822639
[TBL] [Abstract][Full Text] [Related]
9. Hyperplastic foci as a prognostic factor after resection of hepatocellular carcinoma.
Shuto T; Hirohashi K; Wakasa K; Ikebe T; Kinoshita H
Hepatogastroenterology; 1999; 46(28):2439-41. PubMed ID: 10522015
[TBL] [Abstract][Full Text] [Related]
10. The roles of terminal sugar residues of surface glycans in the metastatic potential of human hepatocarcinoma.
Zhang Y; Zhang XY; Liu F; Qi HL; Chen HL
J Cancer Res Clin Oncol; 2002 Nov; 128(11):617-20. PubMed ID: 12458342
[TBL] [Abstract][Full Text] [Related]
11. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
Nakamura S; Nouso K; Noguchi Y; Higashi T; Ono T; Jungbluth A; Chen YT; Old LJ; Nakayama E; Shiratori Y
J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
Fujito T; Sasaki Y; Iwao K; Miyoshi Y; Yamada T; Ohigashi H; Ishikawa O; Imaoka S
Hepatogastroenterology; 2004; 51(58):921-4. PubMed ID: 15239213
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of sialyl Lewis antigen expression in the spread of gastric cancer. Flow cytometric DNA analysis.
Ashizawa T; Aoki T; Yamazaki T; Katayanagi S; Shimizu H; Koyanagi Y
J Exp Clin Cancer Res; 2003 Mar; 22(1):91-8. PubMed ID: 12725328
[TBL] [Abstract][Full Text] [Related]
14. Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer.
Yu CJ; Shih JY; Lee YC; Shun CT; Yuan A; Yang PC
Lung Cancer; 2005 Jan; 47(1):59-67. PubMed ID: 15603855
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
[TBL] [Abstract][Full Text] [Related]
16. Sialyl Lewisa expression as a predictor of the prognosis of colon carcinoma patients in a prospective randomized clinical trial.
Matsui T; Kojima H; Suzuki H; Hamajima H; Nakazato H; Ito K; Nakao A; Sakamoto J
Jpn J Clin Oncol; 2004 Oct; 34(10):588-93. PubMed ID: 15591456
[TBL] [Abstract][Full Text] [Related]
17. Sulfated sialyl Lewis X, the putative L-selectin ligand, detected on endothelial cells of high endothelial venules by a distinct set of anti-sialyl Lewis X antibodies.
Mitsuoka C; Kawakami-Kimura N; Kasugai-Sawada M; Hiraiwa N; Toda K; Ishida H; Kiso M; Hasegawa A; Kannagi R
Biochem Biophys Res Commun; 1997 Jan; 230(3):546-51. PubMed ID: 9015359
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of sialyl Lex expression in human gallbladder carcinoma.
Kashiwagi H; Kijima H; Dowaki S; Ohtani Y; Tobita K; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Imaizumi T; Makuuchi H
Oncol Rep; 2004 Jun; 11(6):1139-43. PubMed ID: 15138547
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.
Yamaguchi R; Yano H; Nakashima O; Akiba J; Nishida N; Kurogi M; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):152-60. PubMed ID: 16706827
[TBL] [Abstract][Full Text] [Related]
20. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
